医学
脑出血
优势比
混淆
他汀类
置信区间
逻辑回归
人口
内科学
丹麦语
药方
条件logistic回归
低风险
儿科
蛛网膜下腔出血
环境卫生
哲学
药理学
语言学
作者
Nils Jensen Boe,Stine Munk Hald,Mie Micheelsen Jensen,Jonas Asgaard Bojsen,Mohammad Talal Elhakim,Sandra Florisson,Alisa Saleh,Anne Clausen,Søren Møller,Frederik Severin Gråe Harbo,Ole Graumann,Jesper Hallas,Luis A. Garcı́a Rodrı́guez,Rustam Al‐Shahi Salman,Larry B. Goldstein,David Garcı́a-Dorado
出处
期刊:Neurology
[Lippincott Williams & Wilkins]
日期:2023-03-07
卷期号:100 (10)
被引量:6
标识
DOI:10.1212/wnl.0000000000201664
摘要
A causal relationship between statin use and intracerebral hemorrhage (ICH) is uncertain. We hypothesized that an association between long-term statin exposure and ICH risk might vary for different ICH locations.We conducted this analysis using linked Danish nationwide registries. Within the Southern Denmark Region (population 1.2 million), we identified all first-ever cases of ICH between 2009 and 2018 in persons aged ≥55 years. Patients with medical record-verified diagnoses were classified as having a lobar or nonlobar ICH and matched for age, sex, and calendar year to general population controls. We used a nationwide prescription registry to ascertain prior statin and other medication use that we classified for recency, duration, and intensity. Using conditional logistic regression adjusted for potential confounders, we calculated adjusted ORs (aORs) and corresponding 95% CIs for the risk of lobar and nonlobar ICH.We identified 989 patients with lobar ICH (52.2% women, mean age 76.3 years) who we matched to 39,500 controls and 1,175 patients with nonlobar ICH (46.5% women, mean age 75.1 years) who we matched to 46,755 controls. Current statin use was associated with a lower risk of lobar (aOR 0.83; 95% CI, 0.70-0.98) and nonlobar ICH (aOR 0.84; 95% CI, 0.72-0.98). Longer duration of statin use was also associated with a lower risk of lobar (<1 year: aOR 0.89; 95% CI, 0.69-1.14; ≥1 year to <5 years aOR 0.89; 95% CI 0.73-1.09; ≥5 years aOR 0.67; 95% CI, 0.51-0.87; p for trend 0.040) and nonlobar ICH (<1 year: aOR 1.00; 95% CI, 0.80-1.25; ≥1 year to <5 years aOR 0.88; 95% CI 0.73-1.06; ≥5 years aOR 0.62; 95% CI, 0.48-0.80; p for trend <0.001). Estimates stratified by statin intensity were similar to the main estimates for low-medium intensity therapy (lobar aOR 0.82; nonlobar aOR 0.84); the association with high-intensity therapy was neutral.We found that statin use was associated with a lower risk of ICH, particularly with longer treatment duration. This association did not vary by hematoma location.
科研通智能强力驱动
Strongly Powered by AbleSci AI